Literature DB >> 24371054

Elimination of mitochondrial DNA is not required for herpes simplex virus 1 replication.

Brett A Duguay1, Holly A Saffran, Alina Ponomarev, Shayla A Duley, Heather E Eaton, James R Smiley.   

Abstract

UNLABELLED: Infection with herpes simplex virus type 1 (HSV-1) results in the rapid elimination of mitochondrial DNA (mtDNA) from host cells. It is known that a mitochondrial isoform of the viral alkaline nuclease (UL12) called UL12.5 triggers this process. However, very little is known about the impact of mtDNA depletion on viral replication or the biology of HSV-1 infections. These questions have been difficult to address because UL12.5 and UL12 are encoded by overlapping transcripts that share the same open reading frame. As a result, mutations that alter UL12.5 also affect UL12, and UL12 null mutations severely impair viral growth by interfering with the intranuclear processing of progeny viral genomes. Therefore, to specifically assess the impact of mtDNA depletion on viral replication, it is necessary to eliminate the activity of UL12.5 while preserving the nuclear functions of UL12. Previous work has shown that the human cytomegalovirus alkaline nuclease UL98 can functionally substitute for UL12 during HSV-1 replication. We found that UL98 is unable to deplete mtDNA in transfected cells and therefore generated an HSV-1 variant in which UL98 coding sequences replace the UL12/UL12.5 open reading frame. The resulting virus was severely impaired in its ability to trigger mtDNA loss but reached titers comparable to those of wild-type HSV-1 in one-step and multistep growth experiments. Together, these observations demonstrate that the elimination of mtDNA is not required for HSV-1 replication in cell culture. IMPORTANCE: Herpes simplex virus types 1 and 2 destroy the DNA of host cell mitochondria, the powerhouses of cells. Epstein-Barr virus, a distantly related herpesvirus, has a similar effect, indicating that mitochondrial DNA destruction is under positive selection and thus confers a benefit to the virus. The present work shows that mitochondrial DNA destruction is not required for efficient replication of herpes simplex virus type 1 in cultured Vero kidney epithelial cells, suggesting that this activity likely benefits the virus in other cell types or in the intact human host.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24371054      PMCID: PMC3958086          DOI: 10.1128/JVI.03129-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Mitochondrial control of cellular life, stress, and death.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Christina Trojel-Hansen; Guido Kroemer
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

2.  Mitochondrial distribution and function in herpes simplex virus-infected cells.

Authors:  T Murata; F Goshima; T Daikoku; K Inagaki-Ohara; H Takakuwa; K Kato; Y Nishiyama
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

3.  Varicella-zoster virus (VZV) mediates a delayed host shutoff independent of open reading frame (ORF) 17 expression.

Authors:  Tim Waterboer; Markus Rahaus; Manfred H Wolff
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

4.  The product of the UL12.5 gene of herpes simplex virus type 1 is not essential for lytic viral growth and is not specifically associated with capsids.

Authors:  Rik Martinez; Joshua N Goldstein; Sandra K Weller
Journal:  Virology       Date:  2002-07-05       Impact factor: 3.616

5.  Binding partners for the UL11 tegument protein of herpes simplex virus type 1.

Authors:  Joshua S Loomis; Richard J Courtney; John W Wills
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  The UL12.5 gene product of herpes simplex virus type 1 exhibits nuclease and strand exchange activities but does not localize to the nucleus.

Authors:  Nina Bacher Reuven; Susumu Antoku; Sandra K Weller
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Varicella-zoster virus open reading frame 48 encodes an active nuclease.

Authors:  Niklaus H Mueller; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

8.  Virus particles produced by the herpes simplex virus type 1 alkaline nuclease null mutant ambUL12 contain abnormal genomes.

Authors:  Iain M Porter; Nigel D Stow
Journal:  J Gen Virol       Date:  2004-03       Impact factor: 3.891

9.  Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover.

Authors:  Britt Glaunsinger; Don Ganem
Journal:  Mol Cell       Date:  2004-03-12       Impact factor: 17.970

10.  Inhibition of host protein synthesis and degradation of cellular mRNAs during infection by influenza and herpes simplex virus.

Authors:  S C Inglis
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

View more
  16 in total

1.  Varicella zoster virus infection of human fetal lung cells alters mitochondrial morphology.

Authors:  Amy C Keller; Hussain Badani; P Mason McClatchey; Nicholas L Baird; Jacqueline L Bowlin; Ron Bouchard; Guey-Chuen Perng; Jane E B Reusch; Benedikt B Kaufer; Don Gilden; Aamir Shahzad; Peter G E Kennedy; Randall J Cohrs
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

Review 2.  Mitochondrial DNA in innate immune responses and inflammatory pathology.

Authors:  A Phillip West; Gerald S Shadel
Journal:  Nat Rev Immunol       Date:  2017-04-10       Impact factor: 53.106

Review 3.  Redox Activation of Mitochondrial DAMPs and the Metabolic Consequences for Development of Autoimmunity.

Authors:  Andreas Koenig; Iwona A Buskiewicz-Koenig
Journal:  Antioxid Redox Signal       Date:  2022-03       Impact factor: 7.468

4.  The UL12 protein of herpes simplex virus 1 is regulated by tyrosine phosphorylation.

Authors:  Hikaru Fujii; Akihisa Kato; Michio Mugitani; Yukie Kashima; Masaaki Oyama; Hiroko Kozuka-Hata; Jun Arii; Yasushi Kawaguchi
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

5.  The Herpes Simplex Virus Virion Host Shutoff Protein Enhances Translation of Viral True Late mRNAs Independently of Suppressing Protein Kinase R and Stress Granule Formation.

Authors:  Bianca Dauber; David Poon; Theodore Dos Santos; Brett A Duguay; Ninad Mehta; Holly A Saffran; James R Smiley
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

6.  Expression of the purine biosynthetic enzyme phosphoribosyl formylglycinamidine synthase in neurons.

Authors:  Colleen A Mangold; Pamela J Yao; Mei Du; Willard M Freeman; Stephen J Benkovic; Moriah L Szpara
Journal:  J Neurochem       Date:  2018-03-26       Impact factor: 5.372

Review 7.  Shutoff of Host Gene Expression in Influenza A Virus and Herpesviruses: Similar Mechanisms and Common Themes.

Authors:  Hembly G Rivas; Summer K Schmaling; Marta M Gaglia
Journal:  Viruses       Date:  2016-04-16       Impact factor: 5.048

8.  Mitochondrial DNA stress primes the antiviral innate immune response.

Authors:  A Phillip West; William Khoury-Hanold; Matthew Staron; Michal C Tal; Cristiana M Pineda; Sabine M Lang; Megan Bestwick; Brett A Duguay; Nuno Raimundo; Donna A MacDuff; Susan M Kaech; James R Smiley; Robert E Means; Akiko Iwasaki; Gerald S Shadel
Journal:  Nature       Date:  2015-02-02       Impact factor: 49.962

9.  Herpes simplex encephalitis is linked with selective mitochondrial damage; a post-mortem and in vitro study.

Authors:  Małgorzata Wnęk; Lorenzo Ressel; Emanuele Ricci; Carmen Rodriguez-Martinez; Julio Cesar Villalvazo Guerrero; Zarini Ismail; Colin Smith; Anja Kipar; Beate Sodeik; Patrick F Chinnery; Tom Solomon; Michael J Griffiths
Journal:  Acta Neuropathol       Date:  2016-07-25       Impact factor: 17.088

10.  Human Cytomegalovirus Infection Upregulates the Mitochondrial Transcription and Translation Machineries.

Authors:  S Karniely; M P Weekes; R Antrobus; J Rorbach; L van Haute; Y Umrania; D L Smith; R J Stanton; M Minczuk; P J Lehner; J H Sinclair
Journal:  mBio       Date:  2016-03-29       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.